Academic Journal
Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025.
| Τίτλος: | Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. |
|---|---|
| Συγγραφείς: | Tagliafico L; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. Electronic address: luca.tagliafico@unige.it., Canevelli M; Department of Human Neuroscience, Sapienza University, Rome, Italy; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden., Barreto PS; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France., Cesari M; Child, Adolescent and Older People Unit, Department of Sexual, Reproductive, Maternal, Child, Adolescent and Ageing Health, World Health Organization, Geneva, Switzerland., Ferrucci L; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Vellas B; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France., Rolland Y; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France. |
| Συλλογικό Έργο: | ICFSR Task Force |
| Πηγή: | The Journal of frailty & aging [J Frailty Aging] 2026 Apr; Vol. 15 (2), pp. 100147. Date of Electronic Publication: 2026 Mar 19. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Serdi Edition Country of Publication: United States NLM ID: 101604797 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2260-1341 (Print) Linking ISSN: 22601341 NLM ISO Abbreviation: J Frailty Aging Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Toulouse : Serdi Edition |
| Ιατρικοί όροι (MeSH): | Sarcopenia*/therapy , Healthy Aging*/physiology , Geroscience*/methods , Frailty*, Aging/physiology ; Humans ; Clinical Trials as Topic ; Advisory Committees ; Biomarkers ; Aged |
| Περίληψη: | The Intrinsic Capacity, Frailty and Sarcopenia Research (ICFSR) Task Force convened in March 2025 to discuss geroscience-oriented pre-clinical and clinical trials aimed at promoting healthy aging. Key topics included the use of aging biomarkers in clinical trials, senotherapeutics, metabolism-targeting medications, and therapeutic strategies beyond pharmacological approaches. The discussions highlighted the growing interest in, and accumulating evidence for, geroscience interventions. Several future challenges were identified, including the need for a deeper understanding of the biology of aging and the validation of aging biomarkers against relevant clinical outcomes, such as frailty and intrinsic capacity. Furthermore, to accelerate innovation in the field, there is a need to enhance clinical trial methodologies and harmonization-for example, by defining a minimum common dataset of biological, physiological, and clinical factors for geroscience clinical studies-and to foster a paradigm shift, particularly among regulatory authorities. (Copyright © 2026. Published by Elsevier Masson SAS.) |
| Competing Interests: | Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Given their role as Editor-in-Chief and Honorary Editor-in-Chief of the Journal of Frailty & Aging, Marco Canevelli and Matteo Cesari were not involved in the peer review of this article and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to another journal Editor. Luca Tagliafico reports to be funded by the Nutrition Research Grant 2025 provided by Nestlé Health Science. Philipe de Souto Barreto reports a relationship with Pfizer that includes funding grants. Luigi Ferrucci reports a relationship with the National Institute on Aging Intramural Research Program. The other Authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The following ICFSR Task Force members are affiliated with or employees of industrial partners: Albert Higgins-Chen: TruDiagnostic; Amos Baruch: Calico Life Sciences; Alexander Casdin and Micah Webster: Empirium Bio; Bashayer Al-Mubarak: Hevolution Foundation; Claire Bigot: Physiogenex; Dobri Kiprov: Global Apheresis Inc. and Circulate; Felipe Sierra: Hevolution Foundation; Gustavo Duque: TSI Pharmaceuticals; Jeroen Aerssens: Rejuvenate Biomed; Jerome Feige: Nestlé Research; John Groarke and Michelle Rossulek: Pfizer Inc.; John Newman: Component Health; Selah Therapeutics, Junevity; Jose Maria Lopez Pedrosa and Suzette Pereira: Abbott Nutrition;Kevin Slawin: Senotherapeutix, Inc.; Leigh Macconell: Hightide Therapeutics; Leila Hicheur and Serge Da Mariana: Groupe IRCEM; Mahajan Ravi: Apollo Hospitals Group; Michelle Rossulek: Pfizer Inc.; Núria Barcons and Stefanie Rau: Nestlé Health Science; Yuta Lee: Accelerated Biosciences. |
| References: | Neural Regen Res. 2026 Mar 1;21(3):1106-1107. (PMID: 39995063) J Nutr Health Aging. 2024 Sep;28(9):100329. (PMID: 39137624) Cell Metab. 2024 Aug 6;36(8):1779-1794.e4. (PMID: 39059384) Nat Commun. 2024 Jun 13;15(1):5046. (PMID: 38871717) Geroscience. 2023 Oct;45(5):2769-2783. (PMID: 37801202) Nat Med. 2024 Sep;30(9):2605-2612. (PMID: 38956196) J Am Geriatr Soc. 2022 Apr;70(4):1082-1094. (PMID: 34951697) Nat Aging. 2025 Mar;5(3):376-385. (PMID: 39900648) J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):447-55. (PMID: 23051977) J Clin Endocrinol Metab. 2023 Jul 14;108(8):1968-1980. (PMID: 36740954) Annu Rev Nutr. 2017 Aug 21;37:51-76. (PMID: 28826372) Cell Rep Med. 2025 Feb 18;6(2):101968. (PMID: 39933528) NPJ Aging. 2024 Feb 6;10(1):12. (PMID: 38321020) Geroscience. 2026 Apr;48(2):2013-2027. (PMID: 41102476) Geroscience. 2024 Apr;46(2):2409-2424. (PMID: 37987886) Lancet. 2015 Jun 6;385(9984):2255-63. (PMID: 25771249) Nat Aging. 2025 Jul;5(7):1207-1216. (PMID: 40467932) J Frailty Aging. 2021;10(3):196-201. (PMID: 34105701) Front Aging Neurosci. 2025 Mar 04;17:1555872. (PMID: 40103928) J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9. (PMID: 27208895) Cell. 2023 Jan 19;186(2):243-278. (PMID: 36599349) Aging Cell. 2024 Jan;23(1):e14034. (PMID: 38038340) Aging Clin Exp Res. 2025 Apr 17;37(1):125. (PMID: 40244306) J Frailty Aging. 2022;11(4):342-347. (PMID: 36346720) J Am Geriatr Soc. 2020 Dec;68(12):2805-2813. (PMID: 32822081) Aging Cell. 2014 Jun;13(3):468-77. (PMID: 24341993) Cell Metab. 2017 Sep 5;26(3):539-546.e5. (PMID: 28877457) Cell Chem Biol. 2025 Jan 16;32(1):174-191.e8. (PMID: 39626664) J Am Nutr Assoc. 2025 Feb;44(2):166-179. (PMID: 39384179) Aging Cell. 2025 Feb;24(2):e14399. (PMID: 39644167) Ageing Res Rev. 2022 Nov;81:101743. (PMID: 36206857) Nat Med. 2024 Feb;30(2):360-372. (PMID: 38355974) Microorganisms. 2025 Jun 13;13(6):. (PMID: 40572269) Ageing Res Rev. 2020 Nov;63:101136. (PMID: 32798771) Geroscience. 2025 Feb;47(1):1123-1138. (PMID: 39120687) Epigenetics. 2024 Dec;19(1):2360160. (PMID: 38820227) Science. 2024 Jun 21;384(6702):1300-1301. (PMID: 38900869) J Adv Nurs. 2025 Sep;81(9):5925-5936. (PMID: 40195235) Aging Cell. 2024 Nov;23(11):e14289. (PMID: 39102875) J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):90-96. (PMID: 35182418) Nature. 2024 May;629(8010):154-164. (PMID: 38649488) JAMA. 2018 Oct 2;320(13):1323-1324. (PMID: 30242384) JAMA. 2020 Nov 10;324(18):1855-1868. (PMID: 33170239) Osteoarthritis Cartilage. 2023 Dec;31(12):1567-1580. (PMID: 37544583) Endocr Rev. 2023 Nov 9;44(6):1047-1073. (PMID: 37364580) Aging (Albany NY). 2017 Feb 14;9(2):419-446. (PMID: 28198702) Mol Aspects Med. 2024 Dec;100:101322. (PMID: 39591800) J Frailty Aging. 2025 Feb;14(1):100010. (PMID: 39855889) Aging Cell. 2025 Aug;24(8):e70103. (PMID: 40424097) Stem Cell Res Ther. 2023 Apr 15;14(1):91. (PMID: 37061744) Nat Aging. 2025 Jan;5(1):87-98. (PMID: 39702725) Biomedicines. 2023 Jul 14;11(7):. (PMID: 37509633) Aging Cell. 2025 Jan;24(1):e14354. (PMID: 39444093) Nat Aging. 2022 Jul;2(7):580-591. (PMID: 37117782) Nat Aging. 2023 Dec;3(12):1474-1479. (PMID: 37985720) Ageing Res Rev. 2023 Jun;87:101908. (PMID: 36905962) Mech Ageing Dev. 2021 Sep;198:111548. (PMID: 34352325) J Nutr Health Aging. 2025 Jan;29(1):100401. (PMID: 39743381) J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5):. (PMID: 39708300) Geroscience. 2022 Dec;44(6):2701-2720. (PMID: 35999337) J Frailty Aging. 2020;9(1):4-8. (PMID: 32150207) Cell Metab. 2017 Sep 5;26(3):547-557.e8. (PMID: 28877458) Aging Cell. 2025 May;24(5):e14489. (PMID: 39823170) Nat Commun. 2023 Aug 19;14(1):5038. (PMID: 37598227) JAMA Netw Open. 2021 Nov 1;4(11):e2134427. (PMID: 34817584) Ageing Res Rev. 2025 Jul;109:102760. (PMID: 40318767) Aging Cell. 2024 Dec;23(12):e14326. (PMID: 39354697) J Gerontol A Biol Sci Med Sci. 2025 Aug 23;80(9):. (PMID: 40729272) Nat Aging. 2025 Oct;5(10):1926-1929. (PMID: 40926125) Cell Mol Immunol. 2023 Jun;20(6):626-650. (PMID: 37095295) J Gerontol A Biol Sci Med Sci. 2025 Feb 10;80(3):. (PMID: 39549299) Cell. 2023 Aug 31;186(18):3758-3775. (PMID: 37657418) Sci Transl Med. 2014 Dec 24;6(268):268ra179. (PMID: 25540326) Stem Cell Res Ther. 2025 Mar 07;16(1):122. (PMID: 40055739) JAMA. 2025 Aug 26;334(8):681-691. (PMID: 40720610) Aging Cell. 2020 Apr;19(4):e13124. (PMID: 32196924) |
| Substance Nomenclature: | 0 (Biomarkers) |
| Entry Date(s): | Date Created: 20260321 Date Completed: 20260711 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13010422 |
| DOI: | 10.1016/j.tjfa.2026.100147 |
| PMID: | 41863810 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.tjfa.2026.100147? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://dx.doi.org/doi:10.1016/j.tjfa.2026.100147 Name: EDS - Springer Nature Journals (s7799221) Category: fullText Text: View record at Springer – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=22601341&ISBN=&volume=15&issue=2&date=20260401&spage=100147&pages=100147&title=The Journal of frailty & aging&atitle=Insights%20on%20geroscience%20pre-clinical%20and%20clinical%20trials%20to%20promote%20healthy%20aging%20from%20the%20Intrinsic%20Capacity%2C%20Frailty%20and%20Sarcopenia%20Research%20Task%20Force%202025.&aulast=Tagliafico%20L&id=DOI:10.1016/j.tjfa.2026.100147 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41863810 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tagliafico+L%22">Tagliafico L</searchLink>; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. Electronic address: luca.tagliafico@unige.it.<br /><searchLink fieldCode="AU" term="%22Canevelli+M%22">Canevelli M</searchLink>; Department of Human Neuroscience, Sapienza University, Rome, Italy; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Barreto+PS%22">Barreto PS</searchLink>; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Cesari+M%22">Cesari M</searchLink>; Child, Adolescent and Older People Unit, Department of Sexual, Reproductive, Maternal, Child, Adolescent and Ageing Health, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferrucci+L%22">Ferrucci L</searchLink>; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Vellas+B%22">Vellas B</searchLink>; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Rolland+Y%22">Rolland Y</searchLink>; IHU HealthAge, Toulouse, France; Institute on Aging, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP, UMR 1295, Université Paul Sabatier, Toulouse, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ICFSR+Task+Force%22">ICFSR Task Force</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101604797%22">The Journal of frailty & aging</searchLink> [J Frailty Aging] 2026 Apr; Vol. 15 (2), pp. 100147. <i>Date of Electronic Publication: </i>2026 Mar 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Serdi+Edition%22">Serdi Edition </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101604797 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2260-1341 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222601341%22">22601341 </searchLink><i>NLM ISO Abbreviation: </i>J Frailty Aging <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Toulouse : Serdi Edition – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Sarcopenia%22">Sarcopenia*</searchLink>/<searchLink fieldCode="MM" term="%22Sarcopenia+therapy%22">therapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Healthy+Aging%22">Healthy Aging*</searchLink>/<searchLink fieldCode="MM" term="%22Healthy+Aging+physiology%22">physiology</searchLink> <br /><searchLink fieldCode="MM" term="%22Geroscience%22">Geroscience*</searchLink>/<searchLink fieldCode="MM" term="%22Geroscience+methods%22">methods</searchLink> <br /><searchLink fieldCode="MM" term="%22Frailty%22">Frailty*</searchLink><br /><searchLink fieldCode="MH" term="%22Aging%22">Aging</searchLink>/<searchLink fieldCode="MH" term="%22Aging+physiology%22">physiology</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Clinical+Trials+as+Topic%22">Clinical Trials as Topic</searchLink> ; <searchLink fieldCode="MH" term="%22Advisory+Committees%22">Advisory Committees</searchLink> ; <searchLink fieldCode="MH" term="%22Biomarkers%22">Biomarkers</searchLink> ; <searchLink fieldCode="MH" term="%22Aged%22">Aged</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The Intrinsic Capacity, Frailty and Sarcopenia Research (ICFSR) Task Force convened in March 2025 to discuss geroscience-oriented pre-clinical and clinical trials aimed at promoting healthy aging. Key topics included the use of aging biomarkers in clinical trials, senotherapeutics, metabolism-targeting medications, and therapeutic strategies beyond pharmacological approaches. The discussions highlighted the growing interest in, and accumulating evidence for, geroscience interventions. Several future challenges were identified, including the need for a deeper understanding of the biology of aging and the validation of aging biomarkers against relevant clinical outcomes, such as frailty and intrinsic capacity. Furthermore, to accelerate innovation in the field, there is a need to enhance clinical trial methodologies and harmonization-for example, by defining a minimum common dataset of biological, physiological, and clinical factors for geroscience clinical studies-and to foster a paradigm shift, particularly among regulatory authorities.<br /> (Copyright © 2026. Published by Elsevier Masson SAS.) – Name: Abstract Label: Competing Interests Group: Ab Data: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Given their role as Editor-in-Chief and Honorary Editor-in-Chief of the Journal of Frailty & Aging, Marco Canevelli and Matteo Cesari were not involved in the peer review of this article and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to another journal Editor. Luca Tagliafico reports to be funded by the Nutrition Research Grant 2025 provided by Nestlé Health Science. Philipe de Souto Barreto reports a relationship with Pfizer that includes funding grants. Luigi Ferrucci reports a relationship with the National Institute on Aging Intramural Research Program. The other Authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The following ICFSR Task Force members are affiliated with or employees of industrial partners: Albert Higgins-Chen: TruDiagnostic; Amos Baruch: Calico Life Sciences; Alexander Casdin and Micah Webster: Empirium Bio; Bashayer Al-Mubarak: Hevolution Foundation; Claire Bigot: Physiogenex; Dobri Kiprov: Global Apheresis Inc. and Circulate; Felipe Sierra: Hevolution Foundation; Gustavo Duque: TSI Pharmaceuticals; Jeroen Aerssens: Rejuvenate Biomed; Jerome Feige: Nestlé Research; John Groarke and Michelle Rossulek: Pfizer Inc.; John Newman: Component Health; Selah Therapeutics, Junevity; Jose Maria Lopez Pedrosa and Suzette Pereira: Abbott Nutrition;Kevin Slawin: Senotherapeutix, Inc.; Leigh Macconell: Hightide Therapeutics; Leila Hicheur and Serge Da Mariana: Groupe IRCEM; Mahajan Ravi: Apollo Hospitals Group; Michelle Rossulek: Pfizer Inc.; Núria Barcons and Stefanie Rau: Nestlé Health Science; Yuta Lee: Accelerated Biosciences. – Name: Ref Label: References Group: RefInfo Data: Neural Regen Res. 2026 Mar 1;21(3):1106-1107. (PMID: <searchLink fieldCode="PM" term="%2239995063%22">39995063)</searchLink><br />J Nutr Health Aging. 2024 Sep;28(9):100329. (PMID: <searchLink fieldCode="PM" term="%2239137624%22">39137624)</searchLink><br />Cell Metab. 2024 Aug 6;36(8):1779-1794.e4. (PMID: <searchLink fieldCode="PM" term="%2239059384%22">39059384)</searchLink><br />Nat Commun. 2024 Jun 13;15(1):5046. (PMID: <searchLink fieldCode="PM" term="%2238871717%22">38871717)</searchLink><br />Geroscience. 2023 Oct;45(5):2769-2783. (PMID: <searchLink fieldCode="PM" term="%2237801202%22">37801202)</searchLink><br />Nat Med. 2024 Sep;30(9):2605-2612. (PMID: <searchLink fieldCode="PM" term="%2238956196%22">38956196)</searchLink><br />J Am Geriatr Soc. 2022 Apr;70(4):1082-1094. (PMID: <searchLink fieldCode="PM" term="%2234951697%22">34951697)</searchLink><br />Nat Aging. 2025 Mar;5(3):376-385. (PMID: <searchLink fieldCode="PM" term="%2239900648%22">39900648)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):447-55. (PMID: <searchLink fieldCode="PM" term="%2223051977%22">23051977)</searchLink><br />J Clin Endocrinol Metab. 2023 Jul 14;108(8):1968-1980. (PMID: <searchLink fieldCode="PM" term="%2236740954%22">36740954)</searchLink><br />Annu Rev Nutr. 2017 Aug 21;37:51-76. (PMID: <searchLink fieldCode="PM" term="%2228826372%22">28826372)</searchLink><br />Cell Rep Med. 2025 Feb 18;6(2):101968. (PMID: <searchLink fieldCode="PM" term="%2239933528%22">39933528)</searchLink><br />NPJ Aging. 2024 Feb 6;10(1):12. (PMID: <searchLink fieldCode="PM" term="%2238321020%22">38321020)</searchLink><br />Geroscience. 2026 Apr;48(2):2013-2027. (PMID: <searchLink fieldCode="PM" term="%2241102476%22">41102476)</searchLink><br />Geroscience. 2024 Apr;46(2):2409-2424. (PMID: <searchLink fieldCode="PM" term="%2237987886%22">37987886)</searchLink><br />Lancet. 2015 Jun 6;385(9984):2255-63. (PMID: <searchLink fieldCode="PM" term="%2225771249%22">25771249)</searchLink><br />Nat Aging. 2025 Jul;5(7):1207-1216. (PMID: <searchLink fieldCode="PM" term="%2240467932%22">40467932)</searchLink><br />J Frailty Aging. 2021;10(3):196-201. (PMID: <searchLink fieldCode="PM" term="%2234105701%22">34105701)</searchLink><br />Front Aging Neurosci. 2025 Mar 04;17:1555872. (PMID: <searchLink fieldCode="PM" term="%2240103928%22">40103928)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9. (PMID: <searchLink fieldCode="PM" term="%2227208895%22">27208895)</searchLink><br />Cell. 2023 Jan 19;186(2):243-278. (PMID: <searchLink fieldCode="PM" term="%2236599349%22">36599349)</searchLink><br />Aging Cell. 2024 Jan;23(1):e14034. (PMID: <searchLink fieldCode="PM" term="%2238038340%22">38038340)</searchLink><br />Aging Clin Exp Res. 2025 Apr 17;37(1):125. (PMID: <searchLink fieldCode="PM" term="%2240244306%22">40244306)</searchLink><br />J Frailty Aging. 2022;11(4):342-347. (PMID: <searchLink fieldCode="PM" term="%2236346720%22">36346720)</searchLink><br />J Am Geriatr Soc. 2020 Dec;68(12):2805-2813. (PMID: <searchLink fieldCode="PM" term="%2232822081%22">32822081)</searchLink><br />Aging Cell. 2014 Jun;13(3):468-77. (PMID: <searchLink fieldCode="PM" term="%2224341993%22">24341993)</searchLink><br />Cell Metab. 2017 Sep 5;26(3):539-546.e5. (PMID: <searchLink fieldCode="PM" term="%2228877457%22">28877457)</searchLink><br />Cell Chem Biol. 2025 Jan 16;32(1):174-191.e8. (PMID: <searchLink fieldCode="PM" term="%2239626664%22">39626664)</searchLink><br />J Am Nutr Assoc. 2025 Feb;44(2):166-179. (PMID: <searchLink fieldCode="PM" term="%2239384179%22">39384179)</searchLink><br />Aging Cell. 2025 Feb;24(2):e14399. (PMID: <searchLink fieldCode="PM" term="%2239644167%22">39644167)</searchLink><br />Ageing Res Rev. 2022 Nov;81:101743. (PMID: <searchLink fieldCode="PM" term="%2236206857%22">36206857)</searchLink><br />Nat Med. 2024 Feb;30(2):360-372. (PMID: <searchLink fieldCode="PM" term="%2238355974%22">38355974)</searchLink><br />Microorganisms. 2025 Jun 13;13(6):. (PMID: <searchLink fieldCode="PM" term="%2240572269%22">40572269)</searchLink><br />Ageing Res Rev. 2020 Nov;63:101136. (PMID: <searchLink fieldCode="PM" term="%2232798771%22">32798771)</searchLink><br />Geroscience. 2025 Feb;47(1):1123-1138. (PMID: <searchLink fieldCode="PM" term="%2239120687%22">39120687)</searchLink><br />Epigenetics. 2024 Dec;19(1):2360160. (PMID: <searchLink fieldCode="PM" term="%2238820227%22">38820227)</searchLink><br />Science. 2024 Jun 21;384(6702):1300-1301. (PMID: <searchLink fieldCode="PM" term="%2238900869%22">38900869)</searchLink><br />J Adv Nurs. 2025 Sep;81(9):5925-5936. (PMID: <searchLink fieldCode="PM" term="%2240195235%22">40195235)</searchLink><br />Aging Cell. 2024 Nov;23(11):e14289. (PMID: <searchLink fieldCode="PM" term="%2239102875%22">39102875)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):90-96. (PMID: <searchLink fieldCode="PM" term="%2235182418%22">35182418)</searchLink><br />Nature. 2024 May;629(8010):154-164. (PMID: <searchLink fieldCode="PM" term="%2238649488%22">38649488)</searchLink><br />JAMA. 2018 Oct 2;320(13):1323-1324. (PMID: <searchLink fieldCode="PM" term="%2230242384%22">30242384)</searchLink><br />JAMA. 2020 Nov 10;324(18):1855-1868. (PMID: <searchLink fieldCode="PM" term="%2233170239%22">33170239)</searchLink><br />Osteoarthritis Cartilage. 2023 Dec;31(12):1567-1580. (PMID: <searchLink fieldCode="PM" term="%2237544583%22">37544583)</searchLink><br />Endocr Rev. 2023 Nov 9;44(6):1047-1073. (PMID: <searchLink fieldCode="PM" term="%2237364580%22">37364580)</searchLink><br />Aging (Albany NY). 2017 Feb 14;9(2):419-446. (PMID: <searchLink fieldCode="PM" term="%2228198702%22">28198702)</searchLink><br />Mol Aspects Med. 2024 Dec;100:101322. (PMID: <searchLink fieldCode="PM" term="%2239591800%22">39591800)</searchLink><br />J Frailty Aging. 2025 Feb;14(1):100010. (PMID: <searchLink fieldCode="PM" term="%2239855889%22">39855889)</searchLink><br />Aging Cell. 2025 Aug;24(8):e70103. (PMID: <searchLink fieldCode="PM" term="%2240424097%22">40424097)</searchLink><br />Stem Cell Res Ther. 2023 Apr 15;14(1):91. (PMID: <searchLink fieldCode="PM" term="%2237061744%22">37061744)</searchLink><br />Nat Aging. 2025 Jan;5(1):87-98. (PMID: <searchLink fieldCode="PM" term="%2239702725%22">39702725)</searchLink><br />Biomedicines. 2023 Jul 14;11(7):. (PMID: <searchLink fieldCode="PM" term="%2237509633%22">37509633)</searchLink><br />Aging Cell. 2025 Jan;24(1):e14354. (PMID: <searchLink fieldCode="PM" term="%2239444093%22">39444093)</searchLink><br />Nat Aging. 2022 Jul;2(7):580-591. (PMID: <searchLink fieldCode="PM" term="%2237117782%22">37117782)</searchLink><br />Nat Aging. 2023 Dec;3(12):1474-1479. (PMID: <searchLink fieldCode="PM" term="%2237985720%22">37985720)</searchLink><br />Ageing Res Rev. 2023 Jun;87:101908. (PMID: <searchLink fieldCode="PM" term="%2236905962%22">36905962)</searchLink><br />Mech Ageing Dev. 2021 Sep;198:111548. (PMID: <searchLink fieldCode="PM" term="%2234352325%22">34352325)</searchLink><br />J Nutr Health Aging. 2025 Jan;29(1):100401. (PMID: <searchLink fieldCode="PM" term="%2239743381%22">39743381)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5):. (PMID: <searchLink fieldCode="PM" term="%2239708300%22">39708300)</searchLink><br />Geroscience. 2022 Dec;44(6):2701-2720. (PMID: <searchLink fieldCode="PM" term="%2235999337%22">35999337)</searchLink><br />J Frailty Aging. 2020;9(1):4-8. (PMID: <searchLink fieldCode="PM" term="%2232150207%22">32150207)</searchLink><br />Cell Metab. 2017 Sep 5;26(3):547-557.e8. (PMID: <searchLink fieldCode="PM" term="%2228877458%22">28877458)</searchLink><br />Aging Cell. 2025 May;24(5):e14489. (PMID: <searchLink fieldCode="PM" term="%2239823170%22">39823170)</searchLink><br />Nat Commun. 2023 Aug 19;14(1):5038. (PMID: <searchLink fieldCode="PM" term="%2237598227%22">37598227)</searchLink><br />JAMA Netw Open. 2021 Nov 1;4(11):e2134427. (PMID: <searchLink fieldCode="PM" term="%2234817584%22">34817584)</searchLink><br />Ageing Res Rev. 2025 Jul;109:102760. (PMID: <searchLink fieldCode="PM" term="%2240318767%22">40318767)</searchLink><br />Aging Cell. 2024 Dec;23(12):e14326. (PMID: <searchLink fieldCode="PM" term="%2239354697%22">39354697)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2025 Aug 23;80(9):. (PMID: <searchLink fieldCode="PM" term="%2240729272%22">40729272)</searchLink><br />Nat Aging. 2025 Oct;5(10):1926-1929. (PMID: <searchLink fieldCode="PM" term="%2240926125%22">40926125)</searchLink><br />Cell Mol Immunol. 2023 Jun;20(6):626-650. (PMID: <searchLink fieldCode="PM" term="%2237095295%22">37095295)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2025 Feb 10;80(3):. (PMID: <searchLink fieldCode="PM" term="%2239549299%22">39549299)</searchLink><br />Cell. 2023 Aug 31;186(18):3758-3775. (PMID: <searchLink fieldCode="PM" term="%2237657418%22">37657418)</searchLink><br />Sci Transl Med. 2014 Dec 24;6(268):268ra179. (PMID: <searchLink fieldCode="PM" term="%2225540326%22">25540326)</searchLink><br />Stem Cell Res Ther. 2025 Mar 07;16(1):122. (PMID: <searchLink fieldCode="PM" term="%2240055739%22">40055739)</searchLink><br />JAMA. 2025 Aug 26;334(8):681-691. (PMID: <searchLink fieldCode="PM" term="%2240720610%22">40720610)</searchLink><br />Aging Cell. 2020 Apr;19(4):e13124. (PMID: <searchLink fieldCode="PM" term="%2232196924%22">32196924)</searchLink> – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Biomarkers) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260321 <i>Date Completed: </i>20260711 <i>Latest Revision: </i>20260813 – Name: DateUpdate Label: Update Code Group: Date Data: 20260813 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13010422 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.tjfa.2026.100147 – Name: AN Label: PMID Group: ID Data: 41863810 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41863810 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.tjfa.2026.100147 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100147 Subjects: – SubjectFull: Aging physiology Type: general – SubjectFull: Humans Type: general – SubjectFull: Clinical Trials as Topic Type: general – SubjectFull: Advisory Committees Type: general – SubjectFull: Biomarkers Type: general – SubjectFull: Aged Type: general – SubjectFull: Sarcopenia therapy Type: general – SubjectFull: Healthy Aging physiology Type: general – SubjectFull: Geroscience methods Type: general – SubjectFull: Frailty Type: general Titles: – TitleFull: Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tagliafico L – PersonEntity: Name: NameFull: Canevelli M – PersonEntity: Name: NameFull: Barreto PS – PersonEntity: Name: NameFull: Cesari M – PersonEntity: Name: NameFull: Ferrucci L – PersonEntity: Name: NameFull: Vellas B – PersonEntity: Name: NameFull: Rolland Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2260-1341 Numbering: – Type: volume Value: 15 – Type: issue Value: 2 Titles: – TitleFull: The Journal of frailty & aging Type: main |
| ResultId | 1 |